Publication | Closed Access
Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling
47
Citations
28
References
2021
Year
InflammationTgf-β/smad SignalingFibrosisMolecular PhysiologyDisease PathophysiologyChronic InflammationPathologyMedicineCell BiologyCell SignalingPeritoneal Fibrosis
| Year | Citations | |
|---|---|---|
Page 1
Page 1